Chemotherapy and targeted therapy in adenoid cystic carcinoma of the head and neck: A review

Head and Neck

Volumn 33, Issue 6, 2011, Pages 905-911

  Papaspyrou, Giorgos ^a   Hoch, Stephan ^a   Rinaldo, Alessandra ^b   Rodrigo, Juan P ^c,d   Takes, Robert P ^e   Van Herpen, Carla ^e   Werner, Jochen A ^a   Ferlito, Alfio ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF UDINE   (Italy)

^c DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

^d HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^e RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

adenoid cystic carcinoma; chemotherapy; head and neck; prognosis; targeted therapy; treatment

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; BORTEZOMIB; CARBOPLATIN; CETUXIMAB; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; ESTROGEN RECEPTOR; FLUOROURACIL; GEFITINIB; GEMCITABINE; IMATINIB; LAPATINIB; MITOXANTRONE; NAVELBINE; PACLITAXEL; PROGESTERONE RECEPTOR; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADENOID CYSTIC CARCINOMA; ANGIOGENESIS; ANTINEOPLASTIC ACTIVITY; BLADDER CANCER; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER INVASION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CELL PROLIFERATION; CHRONIC MYELOID LEUKEMIA; COLORECTAL CANCER; DISTANT METASTASIS; DRUG MECHANISM; DRUG POTENTIATION; FOLLOW UP; GASTROINTESTINAL STROMAL TUMOR; HEAD AND NECK CARCINOMA; HODGKIN DISEASE; HUMAN; LEUKEMIA; LUNG CANCER; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; LYMPHOMA; METASTASIS; MOLECULARLY TARGETED THERAPY; MONOTHERAPY; MULTIPLE MYELOMA; NECK DISSECTION; NEPHROBLASTOMA; NEUTRON THERAPY; NONHODGKIN LYMPHOMA; OSTEOSARCOMA; OVARY CANCER; OVARY CARCINOMA; PANCREAS CANCER; PHASE 2 CLINICAL TRIAL (TOPIC); POINT MUTATION; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; REVIEW; SALIVARY GLAND CANCER; SALIVARY GLAND CARCINOMA; SQUAMOUS CELL CARCINOMA; STOMACH CANCER; TESTIS CARCINOMA; TREATMENT RESPONSE;

ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, ADENOID CYSTIC; DISEASE-FREE SURVIVAL; DRUG DELIVERY SYSTEMS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 79955887119     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21458     Document Type: Review

References (76)

1. Billroth T,. Die Cylindergeschwulst (Cylindroma). In: Untersuchungen über die Entwicklung der Blutgefasse, nebst Beobachtungen aus der königlichen chirurgischen Universitäts-Klinik zu Berlin. Berlin: Reimer; 1856.
2. Robin C, Laboulbéne A,. Mémoire sur trois productions morbides non decrites. C R Soc Biol 1853; 5: 185-196.
3. Spiro RH, Huvos AG, Strong EW,. Adenoid cystic carcinoma of salivary origin: a clinicopathologic study of 242 cases. Am J Surg 1974; 128: 512-520.
4. Bradley PJ,. Adenoid cystic carcinoma of the head and neck: a review. Curr Opin Otolaryngol Head Neck Surg 2004; 12: 127-132. (Pubitemid 38420202)
5. Sanders TE, Ackerman LV, Zimmerman LE,. Epithelial tumors of the lacrimal gland. A comparison of the pathologic and clinical behavior with those of the salivary glands. Am J Surg 1962; 104: 657-665.
6. Pulec JL,. Glandular tumors of the external auditory canal. Laryngoscope 1977; 87: 1601-1612.
7. Miller RH, Calcaterra TC,. Adenoid cystic carcinoma of the nose, paranasal sinuses, and palate. Arch Otolaryngol 1980; 106: 424-426. (Pubitemid 10071627)
8. Liu TR, Yang AK, Guo X, et al. Adenoid cystic carcinoma of the nasopharynx: 27-year experience. Laryngoscope 2008; 118: 1981-1988.
9. Moukarbel RV, Goldstein DP, O'Sullivan B, et al. Adenoid cystic carcinoma of the larynx: a 40-year experience. Head Neck 2008; 30: 919-924. (Pubitemid 352008953)
10. Nishida M, Nasu K, Takai N, Miyakawa I, Kashima K,. Adenoid cystic carcinoma of the uterine cervix. Int J Clin Oncol 2005; 10: 198-200. (Pubitemid 40933696)
11. Hisamatsu H, Sakai H, Igawa T, Iseki M, Hayashi T, Kanetake H,. Adenoid cystic carcinoma of Cowper's gland. BJU Int 2003; 92 (Suppl 3): e56-e57. (Pubitemid 350233549)
12. Wang X, Lu W, Zhu C, Ye F, Xie X,. Adenoid cystic carcinoma of Bartholin's gland with lung metastasis: a case report. Eur J Gynaecol Oncol 2009; 30: 317-320.
13. Balat O, Tercan M, Bekerecioglu M, Aydin A, Karakök M, Kutlar I,. Adenoid cystic carcinoma of the vulva: conservative surgery using a de-epithelized rhomboid flap. Eur J Gynaecol Oncol 2001; 22: 387-388. (Pubitemid 33144552)
14. Karaoglanoglu N, Eroglu A, Turkyilmaz A, Gursan N,. Oesophageal adenoid cystic carcinoma and its management options. Int J Clin Pract 2005; 59: 1101-1103.
15. Hodgson NC, Lytwyn A, Bacopulos S, Elavathil L,. Adenoid cystic breast carcinoma: high rates of margin positivity after breast conserving surgery. Am J Clin Oncol 2010; 33: 28-31.
16. Haresh KP, Prabhakar R, Rath GK, Sharma DN, Julka PK, Subramani V,. Adenoid cystic carcinoma of the trachea treated with PET-CT based intensity modulated radiotherapy. J Thorac Oncol 2008; 3: 793-795.
17. Conley J, Dingman DL,. Adenoid cystic carcinoma in the head and neck (cylindroma). Arch Otolaryngol 1974; 100: 81-90.
18. Marsh WL Jr, Allen MS Jr,. Adenoid cystic carcinoma: biologic behavior in 38 patients. Cancer 1979; 43: 1463-1473. (Pubitemid 9180315)
19. Spiro RH, Huvos AG,. Stage means more than grade in adenoid cystic carcinoma. Am J Surg 1992; 164: 623-628.
20. van der Waal JE, Becking AG, Snow GB, van der Waal I,. Distant metastases of adenoid cystic carcinoma of the salivary glands and the value of diagnostic examinations during follow-up. Head Neck 2002; 24: 779-783. (Pubitemid 34857305)
21. Sur RK, Donde B, Levin V, et al. Adenoid cystic carcinoma of the salivary glands: a review of 10 years. Laryngoscope 1997; 107: 1276-1280. (Pubitemid 27382527)
22. Howard DJ, Lund VJ,. Reflections on the management of adenoid cystic carcinoma of the nasal cavity and paranasal sinuses. Otolaryngol Head Neck Surg 1985; 93: 338-341. (Pubitemid 16015148)
23. Prokopakis EP, Snyderman CH, Hanna EY, Carrau RL, Johnson JT, D'Amico F,. Risk factors for local recurrence of adenoid cystic carcinoma: the role of postoperative radiation therapy. Am J Otolaryngol 1999; 20: 281-286. (Pubitemid 29437254)
24. Fordice RH, Kershaw C, El-Naggar A, Goepfert H,. Adenoid cystic carcinoma of the head and neck: predictors of morbidity and mortality. Arch Otolaryngol Head Neck Surg 1999; 125: 149-152. (Pubitemid 29085262)
25. Oplatek A, Ozer E, Agrawal A, Bapna S, Schuller DE,. Patterns of recurrence and survival of head and neck adenoid cystic carcinoma after definitive resection. Laryngoscope 2010; 120: 65-70.
26. Gomez DR, Hoppe BS, Wolden SL, et al. Outcomes and prognostic variables in adenoid cystic carcinoma of the head and neck: a recent experience. Int J Radiat Oncol Biol Phys 2008; 70: 1365-1372. (Pubitemid 351417750)
27. Sequeiros Santiago G, Rodrigo Tapia JP, Llorente Pendás JL, Suárez Nieto C,. Prognostic factors in adenoid cystic carcinoma of salivary glands. Acta Otorrinolaringol Esp 2005; 56: 361-367 [in Spanish]. (Pubitemid 47251199)
28. Ciccolallo L, Licitra L, Cantú G, Gatta G, EUROCARE Working Group. Survival from salivary glands adenoid cystic carcinoma in European populations. Oral Oncol 2009; 45: 669-674.
29. Vikram B, Strong EW, Shah JP, Spiro RH,. Radiation therapy in adenoid-cystic carcinoma. Int J Radiat Oncol Biol Phys 1984; 10: 221-223. (Pubitemid 14131624)
30. Iseli TA, Karnell LH, Preston TW, et al. Facial nerve sacrifice and radiotherapy in parotid adenoid cystic carcinoma. Laryngoscope 2008; 118: 1781-1786.
31. Prott FJ, Micke O, Haverkamp U, Willich N, Schüller P, Pötter R,. Results of fast neutron therapy of adenoid cystic carcinoma of the salivary glands. Anticancer Res 2000; 20: 3743-3749. (Pubitemid 32002269)
32. Badakhshi H, Marnitz S, Scherer H, Budach V, Haisch A,. Adenoid cystic carcinoma of the oropharynx. Brachytherapy for the treatment of local recurrences HNO 2008; 56: 328-331 [in German].
33. Pommier P, Liebsch NJ, Deschler DG, et al. Proton beam radiation therapy for skull base adenoid cystic carcinoma. Arch Otolaryngol Head Neck Surg 2006; 132: 1242-1249. (Pubitemid 44800140)
34. Dodd RL, Slevin NJ,. Salivary gland adenoid cystic carcinoma: a review of chemotherapy and molecular therapies. Oral Oncol 2006; 42: 759-769. (Pubitemid 44307768)
35. Tannock IF, Sutherland DJ,. Chemotherapy for adenocystic carcinoma. Cancer 1980; 46: 452-454. (Pubitemid 10036634)
36. Schramm VL, Srodes C, Myers EN,. Cisplatin therapy for adenocystic carcinoma. Arch Otolaryngol 1981; 107: 739-741.
37. Suen JY, Johns ME,. Chemotherapy for salivary gland cancer. Laryngoscope 1982; 92: 235-239. (Pubitemid 12187092)
38. Licitra L, Marchini S, Spinazzè S, et al. Cisplatin in advanced salivary gland carcinoma. A phase II study of 25 patients. Cancer 1991; 68: 1874-1877.
39. de Haan LD, de Mulder PHM, Vermorken JB, Schnornagel JH, Vermey A, Verweij J,. Cisplatin-based chemotherapy in advanced adenoid cystic carcinoma of the head and neck. Head Neck 1992; 14: 273-277.
40. Mattox DE, Von Hoff DD, Balcerzak SP,. Southwest Oncology Group study of mitoxantrone for treatment of patients with advanced adenoid cystic carcinoma of the head and neck. Invest New Drugs 1990; 8: 105-107. (Pubitemid 20087254)
41. Verweij J, de Mulder PHM, de Graeff A, et al. Phase II study on mitoxantrone in adenoid cystic carcinomas of the head and neck. EORTC Head and Neck Cancer Cooperative Group. Ann Oncol 1996; 7: 867-869. (Pubitemid 26345882)
42. Vermorken JB, Verweij J, de Mulder PH, et al. Epirubicin in patients with advanced or recurrent adenoid cystic carcinoma of the head and neck: a phase II study of the EORTC Head and Neck Cancer Cooperative Group. Ann Oncol 1993; 4: 785-788. (Pubitemid 23340091)
43. Airoldi M, Pedani F, Succo G, et al. Phase II randomized trial comparing vinorelbine versus vinorelbine plus cisplatin in patients with recurrent salivary gland malignancies. Cancer 2001; 91: 541-547. (Pubitemid 32105699)
44. Gilbert J, Li Y, Pinto HA, et al. Phase II trial of taxol in salivary gland malignancies (E1394): a trial of the Eastern Cooperative Oncology Group. Head Neck 2006; 28: 197-204. (Pubitemid 43269885)
45. van Herpen CM, Locati LD, Buter J, et al. Phase II study on gemcitabine in recurrent and/or metastatic adenoid cystic carcinoma of the head and neck (EORTC 24982). Eur J Cancer 2008; 44: 2542-2545.
46. Rentschler R, Burgess MA, Byers R,. Chemotherapy of malignant major salivary gland neoplasm: a 25-year review of M. D. Anderson Hospital experience. Cancer 1977; 40: 619-624. (Pubitemid 8177876)
47. Vermeer RJ, Pinedo HM,. Partial remission of advanced adenoid cystic carcinoma obtained with adriamycin: a case report with a review of the literature. Cancer 1979; 43: 1604-1606. (Pubitemid 9203704)
48. Licitra L, Cavina R, Grandi C, et al. Cisplatin, doxorubicin and cyclophosphamide in advanced salivary gland carcinoma. A phase II trial of 22 patients. Ann Oncol 1996; 7: 640-642. (Pubitemid 26285647)
49. Hill ME, Constenla DO, A'Hern RP, et al. Cisplatin and 5-fluorouracil for symptom control in advanced salivary adenoid cystic carcinoma. Oral Oncol 1997; 33: 275-278.
50. Dreyfuss AI, Clark JR, Fallon BG, Posner MR, Norris CM Jr, Miller D,. Cyclophosphamide, doxorubicin and cisplatin combination chemotherapy for advanced carcinomas of salivary gland origin. Cancer 1987; 60: 2869-2872. (Pubitemid 18005856)
51. Creagan ET, Woods JE, Schutt AJ, O'Fallon JR,. Cyclophosphamide, adriamycin and cis-diamminedichloroplatinum (II) in the treatment of advanced nonsquamous cell head and neck cancer. Cancer 1983; 52: 2007-2010. (Pubitemid 14232238)
52. Belani CP, Eisenberger MA, Gray WC,. Preliminary experience with chemotherapy in advanced salivary gland neoplasms. Med Pediatr Oncol 1988; 16: 197-202.
53. Dimery IW, Legha SS, Shirinian M, Hong WK,. Fluorouracil, doxorubicin, cyclophosphamide, and cisplatin combination chemotherapy in advanced or recurrent salivary gland carcinoma. J Clin Oncol 1990; 8: 1056-1062. (Pubitemid 20200194)
54. Budd GT, Groppe CW,. Adenoid cystic carcinoma of the salivary gland. Sustained complete response to chemotherapy. Cancer 1983; 51: 589-590. (Pubitemid 13137670)
55. Triozzi PL, Brantley A, Fisher S, Cole TB, Crocker I, Huang AT,. 5-Fluorouracil, cyclophosphamide and vincristine for adenoid cystic carcinoma of the head and neck. Cancer 1987; 59: 887-890. (Pubitemid 17024639)
56. Airoldi M, Fornari G, Pedani F, et al. Paclitaxel and carboplatin for recurrent salivary gland malignancies. Anticancer Res 2000; 20: 3781-3783. (Pubitemid 32002275)
57. Slevin NJ, Mais KL, Bruce I,. Imatinib with cisplatin in recurrent and/or metastatic salivary adenoid cystic carcinoma: response assessed by FDG-PET scanning. J Clin Oncol 2004; 22 (Suppl 14S): 5604 (abstract).
58. Glisson BS, Blumenschein G, Francisco M, Erasmus J, Zinner R, Kies M,. Phase II trial of gefitinib in patients with incurable salivary gland cancer. J Clin Oncol 2005; 23 (Suppl 16S): 5532 (abstract).
59. Hotte SJ, Winquist EW, Lamont E, et al. Imatinib mesylate in patients with adenoid cystic carcinoma of the salivary glands expressing c-kit. A Princess Margaret Hospital phase II consortium study. J Clin Oncol 2005; 23: 585-590. (Pubitemid 46224236)
60. Argiris A, Goldwasser MA, Burtness B, Deconti R, Axelrod R, Van Waes C,. A phase II of PS-341 (bortezomib) followed by the addition of doxorubicin at progression in incurable adenoid cystic carcinoma of the head and neck: an Eastern Cooperative Oncology Group study. Proc Am Soc Clin Oncol 2006; 24 (Suppl 298s): 5573 (abstract).
61. Agulnik M, Cohen EW, Cohen RB, et al. Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non adenoid cystic carcinoma malignant tumors of the salivary glands. J Clin Oncol 2007; 25: 3978-3984. (Pubitemid 47477277)
62. Pfeffer MR, Talmi Y, Catane R, Symon Z, Yosepovitch A, Levitt M,. A phase II study of imatinib for advanced adenoid cystic carcinoma of head and neck salivary glands. Oral Oncol 2007; 43: 33-36. (Pubitemid 46162246)
63. Locati LD, Bossi P, Perrone F, et al. Cetuximab in recurrent and/or metastatic salivary gland carcinomas: a phase II study. Oral Oncol 2009; 45: 574-578.
64. Holst VA, Marshall CE, Moskaluk CA, Frierson HF Jr,. KIT protein expression and analysis of c-kit gene mutation in adenoid cystic carcinoma. Mod Pathol 1999; 12: 956-960. (Pubitemid 29485269)
65. Jeng YM, Lin CY, Hsu HC,. Expression of the c-kit protein is associated with certain subtypes of salivary gland carcinoma. Cancer Lett 2000; 154: 107-111.
66. Sequeiros-Santiago G, García-Carracedo D, Fresno MF, Suarez C, Rodrigo JP, Gonzalez MV,. Oncogene amplification pattern in adenoid cystic carcinoma of the salivary glands. Oncol Rep 2009; 21: 1215-1222.
67. Vila L, Liu H, Al-Quran SZ, Coco DP, Dong HJ, Liu C,. Identification of c-kit gene mutations in primary adenoid cystic carcinoma of the salivary gland. Mod Pathol 2009; 22: 1296-1302.
68. Alcedo JC, Fábrega JM, Arosemena JR, Urrutia A,. Imatinib mesylate as treatment for adenoid cystic carcinoma of the salivary glands: report of two successfully treated cases. Head Neck 2004; 26: 829-831. (Pubitemid 39159307)
69. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL,. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 1987; 235: 177-182. (Pubitemid 17231334)
70. Sainsbury JR, Malcolm AJ, Appleton DR, Farndon JR, Harris AL,. Presence of epidermal growth factor receptors as an indicator of poor prognosis in patients with breast cancer. J Clin Pathol 1985; 38: 1225-1228. (Pubitemid 16215034)
71. Vered M, Braunstein E, Buchner A,. Immunohistochemical study of epidermal growth factor receptor in adenoid cystic carcinoma of salivary gland origin. Head Neck 2002; 24: 632-636. (Pubitemid 34734357)
72. Locati LD, Perrone F, Losa M, et al. Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs). Oral Oncol 2009; 45: 986-990.
73. Shintani S, Funayama T, Yoshihama Y, et al. Expression of c-erbB family gene products in adenoid cystic carcinoma of salivary glands: an immunohistochemical study. Anticancer Res 1995; 15: 2623-2626. (Pubitemid 26095072)
74. Monteiro LS, Bento MJ, Palmeira C, Lopes C,. Epidermal growth factor receptor immunoexpression evaluation in malignant salivary gland tumours. J Oral Pathol Med 2009; 38: 508-513.
75. Shadaba A, Gaze MN, Grant HR,. The response of adenoid cystic carcinoma to tamoxifen. J Laryngol Otol 1997; 111: 1186-1189. (Pubitemid 28040657)
76. Elkin AD, Jacobs CD,. Tamoxifen for salivary gland adenoid cystic carcinoma: report of two cases. J Cancer Res Clin Oncol 2008; 134: 1151-1153.